根据NASDAQ TVTX报道，Travere Therapeutics 公司报告了季度每股亏损 $-0.47，这一数据比分析师普遍预测的 $-0.56 高出 16.07%。相比去年同期每股亏损 $-0.94，有50%的上涨。公司季度销售额为 $7479万，比分析师普遍预测的 $7334万 高出 1.98%。相比去年同期的 $4506万，销售额增长了 65.98%。

以上内容来自Benzinga Earnings专栏，原文如下：

Travere Therapeutics (NASDAQ:TVTX) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.56) by 16.07 percent. This is a 50 percent increase over losses of $(0.94) per share from the same period last year. The company reported quarterly sales of $74.79 million which beat the analyst consensus estimate of $73.34 million by 1.98 percent. This is a 65.98 percent increase over sales of $45.06 million the same period last year.